Shailesh Maingi, Inceptor founder and CEO

Not one, not two, but three — biotech claims it will pur­sue CARs T, M and NK all at once

An on­col­o­gy start­up is tout­ing some re­al­ly, re­al­ly bold claims.

In­cep­tor Bio an­nounced its lat­est round of fund­ing Thurs­day at $37 mil­lion, which it plans on us­ing to back pre­clin­i­cal pro­grams in CARs T, M and NK. Not on­ly will it be flesh­ing out its on­col­o­gy pro­grams, the com­pa­ny says it will al­so be putting some of that fi­nanc­ing to build­ing out its man­u­fac­tur­ing fa­cil­i­ty in Gainesville, FL, which it bought from Mass­a­chu­setts CD­MO Ar­ran­ta Bio late last year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.